Kiniksa Pharmaceuticals International (KNSA) statistics

Analysts' price targets and ratings, ownership, short interest, trading figures and dates for Kiniksa Pharmaceuticals International, as the data feed reports them.

Analysts' mean target, 7 analysts
$111.57
17.3% above the price

The 7 analysts reported by the data feed have a mean price target for Kiniksa Pharmaceuticals International of $111.57, 17.3% above the $95.11 price (range $98.00–$134.00). 10.60% of the float was sold short as of Oct 30, 2026. Institutions hold 101.1% of the shares and insiders 3.5%. Source: Yahoo Finance, read Nov 17, 2026.

Key facts

Analysts' mean target
$111.57+17.3% vs price
Analysts
7
Short interest
10.60%of float, Oct 30, 2026
Short ratio
5.13 days
Institutions
101.1%
Insiders
3.46%
Beta
0.08

Figures read . Source: Yahoo Finance (quoteSummary: key statistics, financial data, recommendation trend, major holders, insider purchases, calendar events). Analysts' targets and ratings, ownership and short interest are the data feed's figures and can lag the filings and exchange reports they come from. Figures, not advice.

Analysts' consensus as reported by the data feed

7 analysts covering Kiniksa Pharmaceuticals International, as the data feed counts them. Price targets and ratings are other people's estimates — not facts about the company, and not advice. Distances are from the latest price the feed gave with these figures, $95.11.

Analysts' price targets for Kiniksa Pharmaceuticals International
Mean price target$111.5717.3% above the price (+17.3%)
Median price target$110.0015.7% above the price (+15.7%)
Highest target$134.0040.9% above the price (+40.9%)
Lowest target$98.003.0% above the price (+3.0%)
Analysts with a target7

Ratings this month · 7 analysts

Strong buy 1(14%)Buy 6(86%)
Analysts' ratings of Kiniksa Pharmaceuticals International this month, by rating
RatingAnalystsShare
Strong buy114%
Buy686%
Hold00%
Sell00%
Strong sell00%

Who owns Kiniksa Pharmaceuticals International

Ownership of Kiniksa Pharmaceuticals International
Held by institutions101.1%427 institutions; percent of shares outstanding
Held by institutions, of the float104.7%
Held by insiders3.46%percent of shares outstanding
Shares outstanding48.84M
Float40.61Mshares available to trade
Insiders' net purchases, six months+803.36K22 purchases (1.49M shares), 7 sales (683.4K shares)

Percentages are of shares outstanding unless the row says float. Insiders' net purchases are shares bought minus shares sold by insiders, as the data feed totals their reported trades.

Short interest as reported by the data feed

Shares sold short and not yet covered, as of Oct 30, 2026. Short interest is counted twice a month, so this is not today's figure.

Short interest in Kiniksa Pharmaceuticals International
Shares short4.29Mas of Oct 30, 2026
Percent of float10.60%shares short ÷ float
Percent of shares outstanding5.47%shares short ÷ shares outstanding
Short ratio (days to cover)5.13shares short ÷ average daily volume

Kiniksa Pharmaceuticals International short interest from FINRA, with its history

Trading figures

Trading figures for Kiniksa Pharmaceuticals International
Beta0.08movement against the market; 1 moves with it
52-week high$99.31
52-week low$37.02
Average volume, 3 months670.27Kshares a day
Average volume, 10 days677.59Kshares a day

Questions and answers

What is the analysts' price target for Kiniksa Pharmaceuticals International (KNSA)?

As reported by the data feed, the mean price target of the 7 analysts covering Kiniksa Pharmaceuticals International is $111.57, 17.3% above the latest price of $95.11. The highest target is $134.00 and the lowest $98.00. Targets are analysts' estimates, not facts about the company and not advice.

How do analysts rate Kiniksa Pharmaceuticals International stock?

Of the 7 ratings the data feed reports for the current month, 1 are strong buy, 6 buy, 0 hold, 0 sell and 0 strong sell.

How many Kiniksa Pharmaceuticals International shares are sold short?

As reported by the data feed, 4.29M shares were sold short, 10.60% of the float as of Oct 30, 2026. At the average daily volume that is 5.13 days to cover. Short interest is reported twice a month; it is not today's figure.

Who owns Kiniksa Pharmaceuticals International stock?

As reported by the data feed, institutions hold 101.1% of the shares (427 institutions) and insiders 3.5%. There are 48.84M shares outstanding, of which 40.61M are in the float.

How much does Kiniksa Pharmaceuticals International stock move with the market?

Its beta, as reported by the data feed, is 0.08: a beta above 1 means the share has tended to move more than the market, below 1 less. Over the past 52 weeks it traded between $37.02 and $99.31.

Cite this page

Funkfolio, “Kiniksa Pharmaceuticals International (KNSA) statistics”, data as of 17 November 2026. https://funkfolio.com/stock/KNSA/statistics

Underlying data: Yahoo Finance.